Omrix Biopharmaceuticals, Inc.
Omrix Biopharmaceuticals, Inc. (OMRI) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 77 transactions totaling $36.1M, demonstrating a bearish sentiment with -$33.1M in net insider flow. The most recent transaction on Nov 23, 2008 involved a transaction of 40,000 shares valued at $0.
OMRI Insider Activity Summary
Who Is Buying OMRI Stock?
No significant insider buying has been recorded for OMRI in the recent period.
Who Is Selling OMRI Stock?
No significant insider selling has been recorded for OMRI in the recent period.
Is Omrix Biopharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OMRI is bearish with an Insider Alignment Score of 4/100 and a net flow of -$33.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
OMRI Frequently Asked Questions
Understanding OMRI Insider Activity
Insider trading at Omrix Biopharmaceuticals, Inc. (OMRI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading OMRI stock, having executed 77 transactions in the past 90 days. The most active insider is Robert Taub (Executive), who has made 6 transactions totaling $24.6M.
Related Tools
Track Omrix Biopharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at OMRI file new Form 4 transactions